SCHEMBL28397844

SCHEMBL28397844

Cc1onc(-c2ccc(S(N)(=O)=O)cc2)c1-c1cccc(S(N)(=O)=O)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.78
PTGS1 P23219 4/20 0.78
MT-CO2 P00403 3/20 0.78
CA1 P00915 3/20 0.78
CA2 P00918 3/20 0.78
CA4 P22748 2/20 0.78
CA7 P43166 2/20 0.78
CA12 O43570 2/20 0.78
CA9 Q16790 2/20 0.78
LMNA P02545 1/20 0.78
CA3 P07451 1/20 0.78
ADRB2 P07550 1/20 0.78
ADRB1 P08588 1/20 0.78
CYP3A4 P08684 1/20 0.78
ADORA3 P0DMS8 1/20 0.78
CHRM1 P11229 1/20 0.78
ADRA2B P18089 1/20 0.78
CA6 P23280 1/20 0.78
SLC6A2 P23975 1/20 0.78
PDE4A P27815 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31213504 0.95 PTGS2 (0.78) PTGS2PTGS1MT-CO2CA1CA2
SCHEMBL6832160 0.93 PTGS2 (0.76) PTGS2PTGS1MT-CO2CA1CA2
SCHEMBL30901200 0.88 PTGS2 (0.76) PTGS2PTGS1MT-CO2CA1CA2
SCHEMBL28679825 0.88 PTGS2 (0.76) PTGS2PTGS1MT-CO2CA1CA2
SCHEMBL30901199 0.88 PTGS2 (0.76) PTGS2PTGS1MT-CO2CA1CA2
Valdecoxib SCHEMBL3356 0.88 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA1CA2
Valdecoxib SCHEMBL3853130 0.88 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA1CA2
SCHEMBL6168344 0.88 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA1CA2
Valdecoxib SCHEMBL6601157 0.86 PTGS2 (0.97) PTGS2PTGS1MT-CO2CA1CA2
Valdecoxib SCHEMBL5999213 0.86 PTGS2 (0.97) PTGS2PTGS1MT-CO2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111153866-A Parecoxib sodium disubstituted impurity and preparation method and application thereof 上海臣邦医药科技股份有限公司 2020-05-15 CN claimed
CN-111153865-A Parecoxib sodium substituted impurity and preparation method thereof 上海臣邦医药科技股份有限公司 2020-05-15 CN disclosed
CN-111153866-A Parecoxib sodium disubstituted impurity and preparation method and application thereof 上海臣邦医药科技股份有限公司 2020-05-15 CN disclosed